Buy Dapagliflozin Powder Anti-diabetic Drug for Type 2 Diabetes Online
What is Dapagliflozin?
Dapagliflozin trade name Farxiga far-SEE-gə in the U.S. and Forxiga in the EU and Russia) is a drug of the gliflozin class.
Dapagliflozin Mechanism of action
Dapagliflozin is in a class of drug called SGLT2 inhibitors. These drugs work by targeting and helping to stop sodium-glucose transport proteins from allowing glucose that has been filtered out of the blood by the kidneys to be reabsorbed back into the blood.
The SGLT2 proteins are responsible for 90% of the glucose that is reabsorbed into the blood. By inhibiting the SGLT2 proteins, Forxiga allows a significant amount of glucose in the blood to be removed by the kidneys and excreted in the urine.
Dapagliflozin Certificate of Analysis
| Product name |
Dapagliflozin |
| CAS No. |
461432-26-8 |
Outer Packing |
100G/bag |
| Production date |
2017.04.21 |
Shelf life |
2019.04.20 |
| Standard adopted |
Enterprise standard |
| Items of analysis |
Specification |
Results |
| Appearance |
White or Off-white powder |
Off-white powder |
| Identification |
HPLC |
Conforms |
| Purity（HPLC） |
≥98% |
99.6% |
| Single Impurity |
≤1.0% |
0.27% |
| Total Impurities |
≤2.0% |
0.40% |
| Conclusion |
Qualified |
Who should not take dapagliflozin?
Dapagliflozin is not suitable for people who:
Have type 1 diabetes
Are pregnant or breastfeeding
Have low kidney function
Are galactose intolerant
Have low salt levels in their body
Are under the age of 18 or over the age 75
Dapagliflozin Side effects
Hypoglycemia –if taken with sulphonylureas or insulin
Thrush
Urinary tract infections
Increased need to visit the toilet (polyuria)
Pain when urinating
Changes in levels of blood fats
Lowering of blood pressure
